| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2025 | Jun 2, 2025 | Alkermes plc. | Director | Sell | 22.5 | -1,924 | -5.75% | ✗ | $58.9K |
| Jun 29, 2024 | Jul 1, 2024 | Alkermes plc. | Director | Sell | 26.3 | -1,465 | -5.45% | ✗ | $35.3K |
| Jul 7, 2023 | Jul 10, 2023 | Alkermes plc. | Director | Sell | 26.3 | -1,430 | -6.44% | ✗ | $42.7K |
| Jun 14, 2022 | Jun 16, 2022 | Alkermes plc. | Director | Sell | 26.3 | -695 | -4.10% | ✗ | $18.9K |
| Mar 4, 2022 | Mar 8, 2022 | Alkermes plc. | Director | Buy | 83.8 | +427 | 4.78% | ✗ | $10K |
| Dec 2, 2021 | Dec 3, 2021 | Alkermes plc. | Director | Sell | 26.3 | -1,339 | -13.03% | ✗ | $29.6K |
| May 20, 2021 | May 21, 2021 | Alkermes plc. | Director | Sell | 26.3 | -1,404 | -23.00% | ✗ | $30.8K |
| Dec 16, 2020 | Dec 17, 2020 | Lyra Therapeutics, Inc. | Director | Buy | 90.0 | +1,025 | 100.00% | ✗ | $10K |